Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation.
Le Meur Y, Büchler M, Thierry A, Caillard S, Villemain F, Lavaud S, Etienne I, Westeel PF, Hurault de Ligny B, Rostaing L, Thervet E, Szelag JC, Rérolle JP, Rousseau A, Touchard G, Marquet P.
Le Meur Y, et al. Among authors: szelag jc.
Am J Transplant. 2007 Nov;7(11):2496-503. doi: 10.1111/j.1600-6143.2007.01983.x. Epub 2007 Oct 1.
Am J Transplant. 2007.
PMID: 17908276
Free article.
Clinical Trial.